Van Houte Hans

EDGAR CIK 0001817217

Nurix Therapeutics, Inc. - NRIX

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CFO
Chief Financial Officer
Direct Buys
0
$0
0 Shares
Direct Sells
4
($293,159)
-23,709 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
11/03/2025
10b5-1
11/03/2025
Sell
-6,284 @ $12.56
 ($78,931) 37,592 (-14.32%) Direct
08/01/2025
10b5-1
08/01/2025
Sell
-5,402 @ $11.03
 ($59,598) 35,512 (-13.20%) Direct
05/02/2025
10b5-1
05/02/2025
Sell
-6,198 @ $11.33
 ($70,243) 33,724 (-15.53%) Direct
03/03/2025
10b5-1
03/03/2025
Sell
-5,825 @ $14.49
 ($84,388) 33,724 (-14.73%) Direct